Rakovina Therapeutics Inc. (TSXV:RKV)
Canada · Delayed Price · Currency is CAD 0.1850
-0.0050 (-2.63%)
Oct 30, 2026, 11:03 AM EDT
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of CAD 8.25 million as of October 30, 2026. It is the 44,063rd most valuable company in the world and the 1,673rd biggest in Canada. Its market cap has increased by 69.59% in one year.
Market Cap
8.25M
Enterprise Value
11.70M
Revenue
n/a
Global Rank
Country Rank
#1,673 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 14.88M to 8.25M, a decrease of -44.55%. That is a compound annual growth rate of -10.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 8.25M | 290.05% |
| Dec 31, 2025 | 2.11M | -92.08% |
| Dec 31, 2024 | 26.69M | 348.09% |
| Dec 29, 2023 | 5.96M | -52.61% |
| Dec 29, 2022 | 12.57M | -18.16% |
| Dec 31, 2021 | 15.36M | 3.25% |
| Apr 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rapid Dose Therapeutics | 13.78M |
| Alzai Health | 12.96M |
| PreveCeutical Medical | 12.76M |
| Hemostemix | 12.69M |
| Britannia Life Sciences | 11.52M |
| Marvel Biosciences | 8.86M |
| COSCIENS Biopharma | 8.78M |
| Glow Lifetech | 7.70M |